Month: October 2017

October 6, 2017 0

Amicus Therapeutics: New Hope on the Horizon for Fabry Disease Patients

By Stephen Callahan

Amicus Therapeutics recently announced that they are seeking FDA approval for a new drug therapy designed to provide effective treatment for the rare condition called Fabry disease. What is Fabry disease and what does this rare condition entail? How does this new medication help control bothersome symptoms associated with Fabry disease? What is Amicus Therapeutics and what do they specialize in? The following information has been designed to answer these important questions. read more